Table 2.
Variable | Mean (±SD) |
---|---|
Age (Years) | 63·1 (10·0) |
BMI (kg m−2) | 28·8 (3·7) |
ALM (kg) | 24·8 (4·0) |
SMI (kg m−2) | 8·3 (1·1) |
ASM% | 29·1 (2·5) |
Body fat% | 35·5 (9·3) |
Waist/Hip ratio | 0·98 (0·06) |
O2peak (ml kg−1 min−1) | 24·0 (5·6) |
O2peak (ml) | 2079·3 (552·6) |
O2peak Lean (ml kg−1 min−1) | 38·5 (8·3) |
VAT (ml kg−1 min−1) | 17·2 (5·1) |
VAT (ml) | 1481·9 (452·4) |
VAT Lean (ml kg−1 min−1) | 27·8 (7·6) |
Peak O2/HR (ml per beat) | 15·5 (3·3) |
Peak HR (bpm) | 134 (20) |
E/CO2 slope | 34·3 (6·0) |
CPET duration (s) | 826·6 (193·8) |
LVEF (%) | 54·3 (6·7) |
Calibre 5‐year risk (%) | 8·3 (7·0) |
NT‐proBNP (pg l−1) | 174·5 (11·4–2735·0) |
hs‐CRP (mg l−1) | 2·3 (3·0) |
Glucose (mmol l−1) | 6·1 (2·0) |
BMI, body mass index; ALM, appendicular lean mass; SMI, skeletal muscle index; ASM%, appendicular skeletal mass; O2peak, peak oxygen uptake; VAT, ventilatory anaerobic threshold; O2/HR, oxygen pulse; HR, heart rate; bpm, bats per minute; E/CO2 slope, ventilatory efficiency with respect to carbon dioxide elimination; CPET, cardiopulmonary exercise test; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro B‐type natriuretic peptide; hs, high sensitivity.